EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Therapeutic Potential of the β3-Adrenergic Receptor and Its Ligands in Cardiovascular Diseases

Marcel Kempiński iD, Paweł Jańczak iD, Adrianna Porębska iD, Patrycja Sandra Zawadzka iD, Paulina Jastrzębska, Marcin Mateusz Granat iD, Małgorzata Wojciechowska iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262411844 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Marcel Kempiński und 6 weiteren Autor:innen. Beteiligte Einrichtung: Chair and Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Banacha 1b…. Hauptthemen laut MEDLINE: Receptors, Adrenergic, beta-3, Cardiovascular Diseases, Adrenergic beta-3 Receptor Agonists. Die Arbeit nennt 276 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The β3-adrenergic receptor is an exceptional member of the β-adrenergic receptor family. Recent findings suggest that it may play a more significant role in the cardiovascular system than previously recognized, partly through its potential anti-inflammatory actions. For this reason, it has been extensively studied as a potential target in cardiovascular therapy. In this review, we focus on the β3-adrenergic receptor agonists and their pharmacodynamics regarding receptor binding and activation. We then describe the mechanisms of action mediated by the β3-adrenergic receptor in blood vessels and in the heart under both physiological and pathological conditions. We particularly concentrate on the therapeutic potential in the arterial, pulmonary, and portal hypertension as well as cardiac arrhythmias, ischemia, and heart failure, considering both receptor agonism and antagonism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Adrenergic, beta-3Cardiovascular DiseasesAdrenergic beta-3 Receptor AgonistsHumansAnimalsLigands

Stichwörter der Autor:innen

adrenergic receptorsagonistsantagonistsarrhythmiasatherosclerosisblood vesselsheartheart failurehypertensionβ3-adrenergic receptor

Substanzen

Receptors, Adrenergic, beta-3LigandsAdrenergic beta-3 Receptor Agonists

Autor:innen und Institutionen

  • Chair and Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Banacha 1b, 02-097 Warsaw, Poland.
  • Department of Clinical and Experimental Pharmacology, Faculty of Medicine, Medical University of Warsaw, Banacha 1b, 02-097 Warsaw, Poland.

ORCID-Profile: Marcel Kempiński, Paweł Jańczak, Adrianna Porębska, Patrycja Sandra Zawadzka, Marcin Mateusz Granat, Małgorzata Wojciechowska

Zitieren

APA

Kempiński, M., Jańczak, P., Porębska, A., Zawadzka, P. S., Jastrzębska, P., Granat, M. M., & Wojciechowska, M. (2025). Therapeutic Potential of the β3-Adrenergic Receptor and Its Ligands in Cardiovascular Diseases. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262411844

Vancouver

Kempiński M, Jańczak P, Porębska A, Zawadzka PS, Jastrzębska P, Granat MM, et al. Therapeutic Potential of the β3-Adrenergic Receptor and Its Ligands in Cardiovascular Diseases. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262411844

BibTeX
@article{Kempiski2025,
  author = {Kempiński, Marcel and Jańczak, Paweł and Porębska, Adrianna and Zawadzka, Patrycja Sandra and Jastrzębska, Paulina and Granat, Marcin Mateusz and Wojciechowska, Małgorzata},
  title = {Therapeutic Potential of the β3-Adrenergic Receptor and Its Ligands in Cardiovascular Diseases},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262411844}
}
Kostenlos starten →